PT98404A - Processo para a preparacao de derivados de 3-(1-pirazoil 1-substituido)-2-oxindole - Google Patents
Processo para a preparacao de derivados de 3-(1-pirazoil 1-substituido)-2-oxindoleInfo
- Publication number
- PT98404A PT98404A PT98404A PT9840491A PT98404A PT 98404 A PT98404 A PT 98404A PT 98404 A PT98404 A PT 98404A PT 9840491 A PT9840491 A PT 9840491A PT 98404 A PT98404 A PT 98404A
- Authority
- PT
- Portugal
- Prior art keywords
- substituted
- pyrazoyl
- oxindole
- biosynthesis
- interleukin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- -1 1-PYRAZOLYL Chemical class 0.000 title 1
- 102000000589 Interleukin-1 Human genes 0.000 abstract 3
- 108010002352 Interleukin-1 Proteins 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- YIBNHAJFJUQSRA-YNNPMVKQSA-N prostaglandin H2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(O)=O YIBNHAJFJUQSRA-YNNPMVKQSA-N 0.000 abstract 3
- 208000037976 chronic inflammation Diseases 0.000 abstract 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 abstract 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940124346 antiarthritic agent Drugs 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/557,265 US5064851A (en) | 1990-07-24 | 1990-07-24 | 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT98404A true PT98404A (pt) | 1992-05-29 |
| PT98404B PT98404B (pt) | 1999-01-29 |
Family
ID=24224706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98404A PT98404B (pt) | 1990-07-24 | 1991-07-22 | Processo para a preparacao de derivados de 3-(1-pirazoil 1-substituido)-2-oxindole |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5064851A (pt) |
| EP (1) | EP0540614B1 (pt) |
| JP (1) | JP2504659B2 (pt) |
| AT (1) | ATE141601T1 (pt) |
| CA (1) | CA2086432C (pt) |
| DE (1) | DE69121571T2 (pt) |
| DK (1) | DK0540614T3 (pt) |
| ES (1) | ES2090345T3 (pt) |
| FI (1) | FI107609B (pt) |
| GR (1) | GR3021291T3 (pt) |
| IE (1) | IE74689B1 (pt) |
| PT (1) | PT98404B (pt) |
| WO (1) | WO1992001684A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698399A (en) * | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| DE69729762T2 (de) | 1997-01-29 | 2005-07-14 | Pfizer Inc. | 4-Substituiertes Furan-2-sulfonamid und dessen Verwendung in der Herstellung von Sulfonylharnstoff-Derivate |
| SI0964849T1 (en) * | 1997-01-29 | 2003-10-31 | Pfizer Inc. | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| CA2327185A1 (en) * | 1998-04-08 | 1999-10-14 | Abbott Laboratories | Pyrazole inhibitors of cytokine production |
| ES2309048T3 (es) * | 2000-01-20 | 2008-12-16 | Nortel Networks Limited | Estructura de tramas para canales inalambricos de velocidad variable que transmiten datos a alta velocidad. |
| EP4008327A1 (en) | 2009-04-29 | 2022-06-08 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3259622A (en) * | 1962-09-07 | 1966-07-05 | Merck & Co Inc | 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids |
| DE3310891A1 (de) * | 1983-03-25 | 1984-09-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
| US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
-
1990
- 1990-07-24 US US07/557,265 patent/US5064851A/en not_active Expired - Lifetime
-
1991
- 1991-06-12 AT AT91913692T patent/ATE141601T1/de not_active IP Right Cessation
- 1991-06-12 ES ES91913692T patent/ES2090345T3/es not_active Expired - Lifetime
- 1991-06-12 DK DK91913692.9T patent/DK0540614T3/da active
- 1991-06-12 EP EP91913692A patent/EP0540614B1/en not_active Expired - Lifetime
- 1991-06-12 WO PCT/US1991/004043 patent/WO1992001684A1/en not_active Ceased
- 1991-06-12 JP JP3513041A patent/JP2504659B2/ja not_active Expired - Fee Related
- 1991-06-12 DE DE69121571T patent/DE69121571T2/de not_active Expired - Fee Related
- 1991-06-12 CA CA002086432A patent/CA2086432C/en not_active Expired - Fee Related
- 1991-07-22 PT PT98404A patent/PT98404B/pt not_active IP Right Cessation
- 1991-07-23 IE IE257491A patent/IE74689B1/en not_active IP Right Cessation
-
1993
- 1993-01-22 FI FI930263A patent/FI107609B/fi not_active IP Right Cessation
-
1996
- 1996-10-09 GR GR960402662T patent/GR3021291T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI107609B (fi) | 2001-09-14 |
| DK0540614T3 (da) | 1996-09-09 |
| CA2086432C (en) | 1997-12-16 |
| PT98404B (pt) | 1999-01-29 |
| JP2504659B2 (ja) | 1996-06-05 |
| ATE141601T1 (de) | 1996-09-15 |
| EP0540614B1 (en) | 1996-08-21 |
| IE74689B1 (en) | 1997-07-30 |
| IE912574A1 (en) | 1992-01-29 |
| WO1992001684A1 (en) | 1992-02-06 |
| US5064851A (en) | 1991-11-12 |
| ES2090345T3 (es) | 1996-10-16 |
| FI930263A0 (fi) | 1993-01-22 |
| FI930263L (fi) | 1993-01-22 |
| DE69121571T2 (de) | 1997-01-09 |
| DE69121571D1 (de) | 1996-09-26 |
| JPH05504773A (ja) | 1993-07-22 |
| EP0540614A1 (en) | 1993-05-12 |
| CA2086432A1 (en) | 1992-01-25 |
| GR3021291T3 (en) | 1997-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2068334T3 (es) | Derivados 3-sustituidos de 2-oxindoles como agentes antiinflamatorios. | |
| BR9915420A (pt) | Composto, composição farmacêutica, métodos de tratar um distúrbio mediado por tnf e por p38 cinase, inflamação e artrite e processo de preparar pirazóis | |
| ES2130452T3 (es) | Derivados de ciclobutano utilizados como inhibidores de la escualeno-sintetasa y de la farnesiltransferasa proteica. | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| BR0310106A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica | |
| WO2002060879A3 (en) | Bacterial gyrase inhibitors and uses thereof | |
| PL322015A1 (en) | Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them | |
| MA30952B1 (fr) | Cyclopenta [d] pyrimidines utiles en tant qu'inhibiteurs de la proteine kinase akt | |
| NZ312840A (en) | Ketoheterocyclic inhibitors of factor Xa | |
| AU2002228991A1 (en) | Methods for treating diseases caused by deficiencies of alpha-l-iduronidase | |
| NO983636D0 (no) | Fremgangsmåte for behandling av trekninger og sykdomstilstander i sentralnervesystemet ved anvendelse av optisk rent (+) norcisaprid | |
| NO922634L (no) | Azaoksindol-derivater | |
| PT98404A (pt) | Processo para a preparacao de derivados de 3-(1-pirazoil 1-substituido)-2-oxindole | |
| BR0115036A (pt) | Processo para a preparação de um composto | |
| EA200300066A1 (ru) | Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции | |
| PT90248A (pt) | Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas como inibidores da biossintese da interleucina-1 | |
| ES2176758T3 (es) | Procedimiento para la preparacion de 4-ciona-1,2,3-triazxoles. | |
| NZ336042A (en) | Farnesyl transferase inhibitors | |
| NO994049L (no) | Metode for aa fremstille farmasöytiske forbindelser | |
| EP1226819A4 (en) | INHIBITORS FOR THE 20-HETE-PRODUCING ENZYME | |
| NO20022361L (no) | Fremgangsmåte for fremstilling av konjugert linolsyre | |
| PT1276722E (pt) | Inibidores de naftamidina-uroquinase | |
| ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
| DK1025101T3 (da) | Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet | |
| FR2627491B1 (fr) | Nouveaux derives du benzocyclohexane et du benzocycloheptane ainsi que leurs sels, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19920122 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19981016 |
|
| MM3A | Annulment or lapse |
Effective date: 20060417 |